Sonoma Pharmaceuticals
SNOA
SNOA
16 hedge funds and large institutions have $54.8K invested in Sonoma Pharmaceuticals in 2023 Q4 according to their latest regulatory filings, with 7 funds opening new positions, 2 increasing their positions, 2 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
44% less capital invested
Capital invested by funds: $97.3K → $54.8K (-$42.5K)
Holders
16
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$37.2K | |
| 2 | +$10.5K | |
| 3 | +$10.2K | |
| 4 |
HF
HRT Financial
New York
|
+$8.88K |
| 5 |
Goldman Sachs
New York
|
+$3.23K |
Top Sellers
| 1 | -$29.7K | |
| 2 | -$11K | |
| 3 | -$198 | |
| 4 |
Osaic Holdings
Scottsdale,
Arizona
|
-$38 |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
-$6 |